Position in ATOS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$254,842
-$318,534 QoQ
Shares Held
132,043
+21.1% QoQ
Ownership
1.32%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 31 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ATOS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. ATOS ranks #241 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in ATOS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $254,842 | 132,043 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $573,376 | 109,007 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,217,074 | 2,062,838 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,347,336 | 1,548,663 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,504,168 | 1,812,251 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,242,917 | 1,855,101 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,464,174 | 1,557,632 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,991,306 | 1,310,070 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,845,582 | 1,550,910 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,495,466 | 1,386,370 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,130,157 | 1,284,270 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $919,353 | 1,242,370 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,353,328 | 1,074,070 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $673,970 | 936,070 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $447,728 | 844,770 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $909,439 | 1,095,710 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,169,094 | 1,989,995 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,625,615 | 2,100,492 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,872,544 | 1,170,340 | Shares | Sole | 2022-02-11 | |
| 2021-03-31 | $6,971,735 | 3,304,140 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $468,160 | 492,800 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $180,241 | 74,480 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||